India, hoping to challenge Chinese dominance, plans API production push: report
The novel coronavirus pandemic has caused a host of problems in the global pharmaceutical supply chain—particularly in China, a major producer of drug ingredients. Now, seeing an opportunity, India is reportedly working on a plan to supersize its own ingredient manufacturing to combat Chinese dominance in the market. The Indian government is planning to escalate domestic production… Read More »